Literature DB >> 15297563

Two novel clinical presentations of Burkholderia cepacia infection.

Chiranjoy Mukhopadhyay1, Anudita Bhargava, Archana Ayyagari.   

Abstract

We report two cases of multidrug-resistant Burkholderia cepacia (B. cepacia genomovar I) and Burkholderia multivorans causing multiple liver abscesses in a patient with bronchial asthma (case 1) and peritonitis in a patient with cirrhosis and hepatitis C virus disease (case 2), respectively. Both patients were treated successfully.

Entities:  

Mesh：

Year:  2004        PMID： 15297563      PMCID： PMC497627          DOI： 10.1128/JCM.42.8.3904-3905.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

Review 1.  A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide.

Authors:  M A Pfaller; R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  1997-08       Impact factor: 2.803

2.  Comparative in vitro activity of meropenem versus other routinely used antimicrobials against 18632 aerobic bacteria tested in 92 German centers.

Authors:  H K Geiss; G Beck
Journal:  Int J Antimicrob Agents       Date:  1998-08       Impact factor: 5.283

3.  Nosocomial meningitis caused by multiply resistant Pseudomonas cepacia.

Authors:  V Krcméry; J Havlík; L Vicianová
Journal:  Pediatr Infect Dis J       Date:  1987-08       Impact factor: 2.129

4.  Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.

Authors:  F Colardyn; K L Faulkner
Journal:  J Antimicrob Chemother       Date:  1996-09       Impact factor: 5.790

5.  Burkholderia cepacia respiratory tract acquisition: epidemiology and molecular characterization of a large nosocomial outbreak.

Authors:  C F Pegues; D A Pegues; D S Ford; P L Hibberd; L A Carson; C M Raine; D C Hooper
Journal:  Epidemiol Infect       Date:  1996-06       Impact factor: 2.451

Review 6.  Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria.

Authors:  R E Hancock
Journal:  Clin Infect Dis       Date:  1998-08       Impact factor: 9.079

7.  Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis.

Authors:  D R Burdge; E M Nakielna; M A Noble
Journal:  Infect Control Hosp Epidemiol       Date:  1993-03       Impact factor: 3.254

8.  Chronic Burkholderia cepacia bronchiectasis in a non-cystic fibrosis individual.

Authors:  M J Ledson; M J Gallagher; M J Walshaw
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

9.  Treatment of Pseudomonas infections in peritoneal dialysis patients.

Authors:  T E Taber; T F Hegeman; S M York; R A Kinney; D H Webb
Journal:  Perit Dial Int       Date:  1991       Impact factor: 1.756

10.  Pseudomonas cepacia colonization and infection in intensive care units.

Authors:  J M Conly; L Klass; L Larson; J Kennedy; D E Low; G K Harding
Journal:  CMAJ       Date:  1986-02-15       Impact factor: 8.262
  10 in total
  6 in total

1.  First isolation of Burkholderia cepacia from a deep neck abscess in a diabetic patient successfully treated with hyperbaric oxygen.

Authors:  Gian Paolo Fadini; Antonio Tiengo; Angelo Avogaro
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

2.  Spontaneous Bacterial Peritonitis by Burkholderia cepacia Complex: A Rare, Difficult to Treat Infection in Decompensated Cirrhotic Patients.

Authors:  Sunil Taneja; Pramod Kumar; Vikas Gautam; Ajay Duseja; Virendra Singh; Radha K Dhiman; Yogesh Chawla
Journal:  J Clin Exp Hepatol       Date:  2016-08-28

3.  Dual Lower Respiratory Tract Infection by Burkholderia cepacia and Acinetobacter baumannii in A Neonate: A Case Report.

Authors:  Neeta Gade; Sanjay Singh Negi; Atul Jindal; Ujjwala Gaikwad; Padma Das; Anudita Bhargava
Journal:  J Clin Diagn Res       Date:  2016-10-01

4.  A rare case of community acquired Burkholderia cepacia infection presenting as pyopneumothorax in an immunocompetent individual.

Authors:  Suman S Karanth; Hariharan Regunath; Kiran Chawla; Mukhyaprana Prabhu
Journal:  Asian Pac J Trop Biomed       Date:  2012-02

5.  Clinical and Microbiological Profile of Patients with Bloodstream Infections Caused by Burkholderia cepacia Complex.

Authors:  Tasneem Siddiqui; Chinmoy Sahu; Sangram Singh Patel; Ujjala Ghoshal
Journal:  J Lab Physicians       Date:  2022-02-09

6.  Burkholderia cepacia complex in Indian cystic fibrosis patients.

Authors:  Vikas Gautam; Meenu Singh; Lipika Singhal; Mandeep Kaur; Ashok Kumar; Pallab Ray
Journal:  Indian J Med Res       Date:  2012-11       Impact factor: 2.375
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.